Colgate-Palmolive (NYSE:CL) Shares Sold by US Bancorp DE

US Bancorp DE lessened its holdings in shares of Colgate-Palmolive (NYSE:CL) by 0.5% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 387,966 shares of the company’s stock after selling 1,998 shares during the quarter. US Bancorp DE’s holdings in Colgate-Palmolive were worth $35,270,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of CL. Swedbank AB increased its stake in shares of Colgate-Palmolive by 1.4% in the third quarter. Swedbank AB now owns 2,950,059 shares of the company’s stock worth $306,246,000 after buying an additional 40,324 shares during the last quarter. Reston Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive in the 3rd quarter valued at about $42,000. Stephens Inc. AR lifted its position in shares of Colgate-Palmolive by 2.1% during the third quarter. Stephens Inc. AR now owns 11,951 shares of the company’s stock worth $1,241,000 after purchasing an additional 251 shares during the last quarter. Creative Financial Designs Inc. ADV grew its stake in Colgate-Palmolive by 142.1% in the third quarter. Creative Financial Designs Inc. ADV now owns 869 shares of the company’s stock worth $90,000 after purchasing an additional 510 shares in the last quarter. Finally, Gladstone Institutional Advisory LLC increased its holdings in Colgate-Palmolive by 10.3% in the third quarter. Gladstone Institutional Advisory LLC now owns 6,758 shares of the company’s stock valued at $702,000 after buying an additional 631 shares during the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Up 1.2 %

Colgate-Palmolive stock opened at $91.27 on Friday. The company’s 50-day moving average price is $88.74 and its two-hundred day moving average price is $95.48. The stock has a market cap of $74.07 billion, a price-to-earnings ratio of 25.93, a PEG ratio of 4.20 and a beta of 0.44. Colgate-Palmolive has a 52 week low of $85.32 and a 52 week high of $109.30. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the prior year, the business earned $0.87 earnings per share. On average, analysts expect that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.19%. The ex-dividend date was Tuesday, January 21st. Colgate-Palmolive’s payout ratio is currently 56.82%.

Analysts Set New Price Targets

Several brokerages have recently commented on CL. Morgan Stanley decreased their target price on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research report on Monday, February 3rd. TD Cowen decreased their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a report on Wednesday, January 8th. Wells Fargo & Company decreased their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. UBS Group dropped their price objective on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a research note on Monday, February 3rd. Finally, Royal Bank of Canada restated a “sector perform” rating and issued a $101.00 target price on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $101.61.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.